Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.

Autor: Blum K; Division of Addiction Research & Education, Center for Psychiatry, Medicine, & Primary Care (Office of the Provost), Western University Health Sciences, Pomona, CA 91766, USA.; Institute of Psychology, Eotvos Loránd University, 1053 Budapest, Hungary.; Division of Nutrigenomics, Synaptamine Inc., Austin, TX 78701, USA.; Department of Psychiatry, Wright State University Boonshoft School of Medicine and Dayton VA Medical Center, Dayton, OH 45435, USA.; Department of Psychiatry, University of Vermont, Burlington, VT 05405, USA.; Division of Precision Addiction Management, Geneus Health (Division of Ivitalize Inc.), San Antonio, TX 78249, USA.; Division of Nutrigenomics, The Kenneth Blum Behavioral & Neurogenetic Institute (Division of Ivitalize Inc.), Austin, TX 78701, USA., Bowirrat A; Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 40700, Israel., Braverman ER; Division of Nutrigenomics, The Kenneth Blum Behavioral & Neurogenetic Institute (Division of Ivitalize Inc.), Austin, TX 78701, USA., Baron D; Division of Addiction Research & Education, Center for Psychiatry, Medicine, & Primary Care (Office of the Provost), Western University Health Sciences, Pomona, CA 91766, USA., Cadet JL; Molecular Neuropsychiatry Research Branch, NIH National Institute on Drug Abuse, Bethesda, MD 20892, USA., Kazmi S; Division of Addiction Research & Education, Center for Psychiatry, Medicine, & Primary Care (Office of the Provost), Western University Health Sciences, Pomona, CA 91766, USA., Elman I; Department of Psychiatry, Harvard School of Medicine, Cambridge, MA 02115, USA., Thanos PK; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY 14260, USA., Badgaiyan RD; Department of Psychiatry, South Texas Veteran Health Care System, Audie L. Murphy Memorial VA Hospital, San Antonio, TX 78229, USA.; Long School of Medicine, University of Texas Medical Center, San Antonio, TX 78229, USA., Downs WB; Division of Nutrigenomics, The Kenneth Blum Behavioral & Neurogenetic Institute (Division of Ivitalize Inc.), Austin, TX 78701, USA., Bagchi D; Division of Nutrigenomics, The Kenneth Blum Behavioral & Neurogenetic Institute (Division of Ivitalize Inc.), Austin, TX 78701, USA.; Department of Pharmaceutical Sciences, College of Pharmacy, Southern University, Houston, TX 77004, USA., Llanos-Gomez L; Division of Nutrigenomics, The Kenneth Blum Behavioral & Neurogenetic Institute (Division of Ivitalize Inc.), Austin, TX 78701, USA., Gold MS; Department of Psychiatry, Tulane University School of Medicine, New Orleans, LA 70118, USA.; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63130, USA.

Publikováno v: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Nov 02; Vol. 18 (21). Date of Electronic Publication: 2021 Nov 02.

Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.

Autor: Fried L; Department of Precision Addiction Management, Geneus Health, LLC., San Antonio, TX, United States.; Transformations Treatment Center, Delray Beach, FL, United States., Modestino EJ; Department of Precision Addiction Management, Geneus Health, LLC., San Antonio, TX, United States.; Department of Psychology, Curry College, Milton, MA, United States., Siwicki D; Department of Precision Addiction Management, Geneus Health, LLC., San Antonio, TX, United States., Lott L; Department of Precision Addiction Management, Geneus Health, LLC., San Antonio, TX, United States., Thanos PK; Department of Precision Addiction Management, Geneus Health, LLC., San Antonio, TX, United States.; Behavioral Neuropharmacology & Neuroimaging Laboratory on Addiction, Research Institute on Addictions, University of Buffalo, Buffalo, NY, United States., Baron D; Department of Precision Addiction Management, Geneus Health, LLC., San Antonio, TX, United States.; Graduate School of Biomedical Sciences, Western University Health Sciences, Pomona, CA, United States., Badgaiyan RD; Department of Precision Addiction Management, Geneus Health, LLC., San Antonio, TX, United States.; Department of Psychiatry, Icahn School of Medicine, New York, NY, United States., Ponce JV; Department of Precision Addiction Management, Geneus Health, LLC., San Antonio, TX, United States., Giordano J; John Giordano, Life Enhancement Recovery Center, Hollywood, FL, United States., Downs WB; Victory Nutrition International, Lederach, PA, United States., Gondré-Lewis MC; Department of Anatomy, Developmental Neuro-Psycho-Pharmacology Laboratory, Howard University College of Medicine, Washington, DC, United States., Bruce S; Department of Psychology, Curry College, Milton, MA, United States., Braverman ER; Department of Clinical Neurology, PATH Foundation, New York, NY, United States., Boyett B; Division of Neuroscience & Addiction Research, Pathway Healthcare, Birmingham, AL, United States., Blum K; Department of Precision Addiction Management, Geneus Health, LLC., San Antonio, TX, United States.; Graduate School of Biomedical Sciences, Western University Health Sciences, Pomona, CA, United States.; John Giordano, Life Enhancement Recovery Center, Hollywood, FL, United States.; Victory Nutrition International, Lederach, PA, United States.; Department of Clinical Neurology, PATH Foundation, New York, NY, United States.; Division of Neuroscience & Addiction Research, Pathway Healthcare, Birmingham, AL, United States.; Division of Addiction Services, Dominion Diagnostics, LLC, North Kingstown, RI, United States.; Department of Psychiatry, University of Vermont, Burlington, VM, United States.; Eotvos Loránd University, Institute of Psychology, Budapest, Hungary.; Department of Psychiatry, Wright State University, Boonshoft School of Medicine and Dayton VA, Medical Center, Dayton, OH, United States.

Publikováno v: Current pharmaceutical biotechnology [Curr Pharm Biotechnol] 2020; Vol. 21 (6), pp. 528-541.

Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.

Autor: Blum K; Department of Psychiatry and McKnight Brain Institute, University of Florida, College of Medicine, Gainesville, Florida, USA ; Department of Nutrigenomics, LifeGen, Inc. Austin, Texas, USA ; Dominion Diagnostics, Inc. North Kingstown, Rhode Island, USA., Oscar-Berman M, Femino J, Waite RL, Benya L, Giordano J, Borsten J, Downs WB, Braverman ER, Loehmann R, Dushaj K, Han D, Simpatico T, Hauser M, Barh D, McLaughlin T

Publikováno v: Journal of addiction research & therapy [J Addict Res Ther] 2013 Apr 23; Vol. 4 (2).

Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.

Autor: Chen TJ; Department of Occupational Safety and Health, Chang Jung Christian University, Taiwan, Republic of China., Blum K, Chen AL, Bowirrat A, Downs WB, Madigan MA, Waite RL, Bailey JA, Kerner M, Yeldandi S, Majmundar N, Giordano J, Morse S, Miller D, Fornari F, Braverman ER

Publikováno v: Journal of psychoactive drugs [J Psychoactive Drugs] 2011 Apr-Jun; Vol. 43 (2), pp. 108-27.